Heparegenix raised €11M in a Series B round in Jan 2020. The company is based in Ulm, Germany. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €11M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
This is the company's only recorded round.
